New Therapeutic Vaccine Gives Hope Against an Aggressive Breast Cancer
The vaccine appears to be safe and effective against triple-negative breast cancer -- a type that can’t be treated with ...
Wash U vaccine trial shows promising data in preventing breast cancer recurrence
A groundbreaking treatment has been announced for women with an extremely aggressive form of breast cancer. Siteman Cancer ...
Domestic7h
This Scientist Treated Her Own Breast Cancer Using Lab-Grown Virus
Dr. Beata Halassy, a 49-year-old virologist, self-treated her recurrent breast cancer with OVT, a method that leverages ...
Breast cancer break through as new vaccine shows 'promise' in treating aggressive form
Researchers say the results mark the first time a vaccine - known as a neoantigen DNA vaccine - has shown such positive ...
Intensity Therapeutics Reports Third Quarter 2024 Financial Results And Provides Corporate Update
First patient dosed in randomized, Phase 2 study in presurgical triple negative breast cancer SHELTON, Conn., Nov. 13, 20 ...
Stories by SWNS on MSN15h
Breast cancer hope as vaccine shows “promising” results
Breast cancer patients have been given fresh hope after a new vaccine showed “promise” in treating an aggressive form of the ...
‘It doesn’t define me’: Breast cancer survivor shares inspiring message during tough battle, encourages women to prioritize screenings year-round
A McGregor woman, who survived a tough battle with breast cancer, is sharing her journey to emphasize the importance of ...
BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition
On Wednesday, BioNTech SE (NASDAQ:BNTX) agreed to acquire Biotheus, a clinical-stage biotechnology company focused on ...
pharmaphorum20h
BioNTech buys Biotheus and its Keytruda rival for $950m
BioNTech said that BNT327 has the "potential to replace current checkpoint inhibitor standard of care treatments for solid ...
Mersana Therapeutics, Inc.: Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results
Plan to announce initial clinical data for XMT-1660 at a company event by the end of 2024 Dose escalation advancing in Phase 1 clinical trial of XMT-2056 Conference call today at 8:00 a.m. ET CAMBRIDG ...
The Times of Northwest Indiana23h
Get Healthy: Few answers as cancer, heart disease become more common in young people
Brittany Pieniazek knew she had a chance of developing breast cancer. The Dyer resident’s mother and aunt had both been ...